- Package
- 1 g
- Purity
- 99%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 1310726-60-3
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
1310726-60-3
PubChem CID
58557659
Molecular Formula
C17H19F3N6O
Molecular Weight
380.4 g/mol
Exact Mass
380.157244
InChIKey
WYQFJHHDOKWSHR-MNOVXSKESA-N
IUPAC Name
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
SMILES String
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12
No physical property values available.
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Upadacitinib (CAS 1310726-60-3) is listed in the Advanced Chemicals portfolio, with molecular formula C17H19F3N6O and molecular weight 380. 40 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Tyrosine-protein kinase JAK1 (Homo sapiens) — 42 assays; Tyrosine-protein kinase JAK2 (Homo sapiens) — 34 assays; Tyrosine-protein kinase JAK3 (Homo sapiens) — 27 assays; JAK3/JAK1 (Homo sapiens) — 5 assays; JAK2/JAK1 (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Tyrosine-protein kinase JAK1
Homo sapiens · SINGLE PROTEIN · 42 qualifying assays · 22 documents · best pChEMBL 9.1
Experimental evidence source: ChEMBL
Tyrosine-protein kinase JAK2
Homo sapiens · SINGLE PROTEIN · 34 qualifying assays · 15 documents · best pChEMBL 8.8
Experimental evidence source: ChEMBL
Tyrosine-protein kinase JAK3
Homo sapiens · SINGLE PROTEIN · 27 qualifying assays · 10 documents · best pChEMBL 8.8
Experimental evidence source: ChEMBL
JAK3/JAK1
Homo sapiens · PROTEIN COMPLEX · 5 qualifying assays · 2 documents · best pChEMBL 8.7
Experimental evidence source: ChEMBL
JAK2/JAK1
Homo sapiens · PROTEIN COMPLEX · 2 qualifying assays · 1 documents · best pChEMBL 8.52
Experimental evidence source: ChEMBL
Safety and handling reference content is available through documentation requests.
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Upadacitinib is identified by CAS 1310726-60-3, with molecular formula C17H19F3N6O, molecular weight 380.4, InChIKey WYQFJHHDOKWSHR-MNOVXSKESA-N.
ChEMBL contains qualifying experimental assay evidence associated with Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase JAK3, JAK3/JAK1, JAK2/JAK1. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.